baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Adicet Bio Inc/ US0070021086 /

7/10/2024 10:00:00 PM	Chg. +0.0600	Volume	Bid1:50:01 AM	Ask1:50:01 AM	High	Low
1.2700USD	+4.96%	1.24 mill. Turnover: 1.02 mill.	1.2700Bid Size: 300	1.3100Ask Size: 200	1.3000	1.2050

GlobeNewswire 12/10/2021 Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of...

GlobeNewswire 12/8/2021 Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock

GlobeNewswire 12/7/2021 Adicet Bio, Inc. Announces Proposed Follow-On Offering of Common Stock

GlobeNewswire 12/6/2021 Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma...

GlobeNewswire 11/29/2021 Adicet Bio to Host Webcast Presentation of ADI-001 Interim Clinical Data in B Cell Non-Hodgkin’s Lym...

GlobeNewswire 11/18/2021 Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors

GlobeNewswire 11/12/2021 Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors...

GlobeNewswire 11/10/2021 Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates

GlobeNewswire 11/8/2021 Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference

GlobeNewswire 11/4/2021 Adicet Announces Trials in Progress Poster Presentation for ADI-001 at 2021 ASH Annual Meeting

GlobeNewswire 10/12/2021 Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer

GlobeNewswire 10/4/2021 Adicet to Present Preclinical Data from Allogeneic Gamma Delta T Cell Platform at SITC 36th Annual M...

GlobeNewswire 9/13/2021 Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer T...

GlobeNewswire 9/2/2021 Adicet Bio to Participate in Upcoming Investor Conferences

GlobeNewswire 8/12/2021 Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates

GlobeNewswire 8/3/2021 GBT Reports Second Quarter 2021 Financial Results

GlobeNewswire 8/2/2021 Oyster Point Pharma Announces New Chairperson Appointment to Board of Directors

GlobeNewswire 7/15/2021 Adicet Bio Announces Formation of Scientific Advisory Board

GlobeNewswire 6/28/2021 Adicet Bio Added to the Russell 2000® Index

GlobeNewswire 5/18/2021 Adicet Bio to Participate in Upcoming Investor Conferences

GlobeNewswire 5/17/2021 Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates

GlobeNewswire 4/29/2021 Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit

GlobeNewswire 4/15/2021 Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

GlobeNewswire 4/13/2021 Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research

GlobeNewswire 3/11/2021 Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Adicet Bio Inc/ US0070021086 /

If you wish to receive reply to your feedback, please provide your email address.